Research
ASCO Annual Meeting
The world's most influential oncology meeting, where life science investors and clinicians evaluate landmark cancer clinical trial results.
- When
- May, Late May
- Where
- Chicago, United States
- Format
- Hybrid
- Organiser
- American Society of Clinical Oncology
- Region
- Global
- Scale
- About 40,000 attendees
- Founded
- 1964
The briefing
While primarily a clinical oncology conference, the ASCO Annual Meeting is a massive event for life science investors and biotechnology companies. It is the premier venue for releasing late-breaking clinical trial data for new cancer therapies and digital therapeutics. Investment firms carefully analyze these presentations to evaluate biotechnology pipeline assets and market potential. The meeting shapes oncology treatment standards and stock valuations across the global biopharma sector.
What to expect
- Late-breaking clinical trial data releases
- FDA drug approval strategy updates
- Oncology AI diagnostic model performance data
- Biotech pipeline evaluation panels
Who is in the room
Oncologists, clinical researchers, biotechnology executives, life science analysts, and institutional investors attend.
Background
ASCO was founded in 1964 by a small group of oncologists. The annual meeting has grown into a massive scientific forum that dictates the clinical and investment direction of oncology therapeutics.
Related events
Running this event, or spotted something out of date?